HysensBio Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.hysensbio.com
Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- HysensBio Co., Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT06464939
- Locations
- 🇺🇸
Forsyth Institute, Cambridge, Massachusetts, United States
🇺🇸ADA Forsyth, Cambridge, Massachusetts, United States
A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- HysensBio Co., Ltd
- Target Recruit Count
- 171
- Registration Number
- NCT06264453
- Locations
- 🇰🇷
Kyung Hee University Dental Hospital, Seoul, Korea, Republic of
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- HysensBio Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT04804514
- Locations
- 🇰🇷
Seoul National University Dental Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath